|
2024
|
Invention
|
Combination therapies of wdr5 inhibitors and pd-1 inhibitors. Provided herein are combination the... |
|
|
Invention
|
Combination therapies of wdr5 inhibitors and pd-1 inhibitors.
Provided herein are combination th... |
|
|
Invention
|
Combination therapies of hdac inhibitors and pd-1 inhibitors.
Provided herein are combinations t... |
|
|
Invention
|
Methods and compositions comprising a cardio-tolerated hdac inhibitor. Provided herein are method... |
|
|
Invention
|
Methods and compositions comprising a cardio-tolerated hdac inhibitor.
Provided herein are metho... |
|
2023
|
Invention
|
Sulcardine administration for treatment of acute atrial fibrillation.
Provided herein are compos... |
|
|
Invention
|
Combination therapies comprising kras inhibitors and sph2 inhibitors.
Provided herein are combin... |
|
|
Invention
|
Combination therapies comprising kras inhibitors and sph2 inhibitors. Provided herein are combina... |
|
|
Invention
|
Sulcardine administration for treatment of acute atrial fibrillation 94919.0739.717301us.
Provid... |
|
|
Invention
|
Combination therapies of wdr-5 inhibitors and pd-1 inhibitors.
Provided herein are combinations ... |
|
|
Invention
|
Combination therapies of wdr5 inhibitors and pd-1 inhibitors |
|
|
Invention
|
Combination therapies of wdr5 inhibitors and pd-1 inhibitors. Provided herein are combinations th... |
|
|
Invention
|
Haloalkylpyridyl triazole mll1-wdr5 protein-protein interaction inhibitor. Described herein are a... |
|
|
Invention
|
Blood-brain barrier crossing mll1-wdr5 protein-protein interaction inhibitor compounds and uses t... |
|
|
Invention
|
Mll1-wdr5 protein-protein interaction inhibitor compounds and uses thereof.
Described herein are... |
|
|
Invention
|
Phenyl triazole mll1-wdr5 protein-protein interaction inhibitor. Described herein are a phenyl tr... |
|
|
Invention
|
Haloalkylpyridyl triazole mll1-wdr5 protein-protein interaction inhibitor.
Described herein are ... |
|
|
Invention
|
Phenyl triazole mll1-wdr5 protein-protein interaction inhibitor.
Described herein are a phenyl t... |
|
2022
|
G/S
|
Pharmaceutical preparations for prophylactic, diagnostic and/or therapeutic uses in the treatment... |
|
|
Invention
|
Combination therapies of hdac inhibitors and pd-l1 inhibitors.
Provided herein are combinations ... |
|
|
Invention
|
Compositions and methods for inhibiting phenyl triazole mll1-wdr5 protein-protein interaction. Th... |
|
|
Invention
|
Sulcardine salts.
Sulcardine salts other than sulfuric acid salts of sulcardine, including cryst... |
|
|
Invention
|
Sulcardine administration for treatment of acute atrial fibrillation. Provided herein are composi... |
|
|
Invention
|
Combination therapies comprising shp2 inhibitors and egfr tyrosine kinase inhibitors.
Provided h... |
|
|
Invention
|
Combination therapies comprising shp2 inhibitors and pd-1 inhibitors. Provided herein are combina... |
|
|
Invention
|
Shp2 inhibitor monotherapy and uses thereof.
Provided herein are SHP2 inhibitors for use in the ... |
|
|
Invention
|
Shp2 inhibitor monotherapy and uses thereof. Provided herein are SHP2 inhibitors for use in the r... |
|
|
Invention
|
Combination therapies comprising shp2 inhibitors and egfr tyrosine kinase inhibitors. Provided he... |
|
2021
|
Invention
|
Methods and compositions for genetic modulation of tumor microenvironments.
Provided herein is a... |
|
|
Invention
|
Methods and compositions for genetic modulation of tumor microenvironments. Provided herein is a ... |
|
|
G/S
|
Pharmaceutical preparations for prophylactic, diagnostic and therapeutic uses in the treatment of... |
|
|
G/S
|
Pharmaceutical preparations for prophylactic, diagnostic
and/or therapeutic uses in the treatmen... |
|
2020
|
Invention
|
Sulcardine salts. Sulcardine salts other than sulfuric acid salts of sulcardine, including crysta... |
|
|
Invention
|
Triplet therapies of hdac inhibitors, pd-l1 and/or pd-1 inhibitors, and ctla-4 inhibitors.
Provi... |
|
2019
|
Invention
|
Combination therapies of hdac inhibitors and pd-l1 inhibitors. Provided herein are combinations t... |
|
|
Invention
|
Combination therapies of hdac inhibitors and pd-1 inhibitors. Provided herein are combinations th... |
|
2017
|
Invention
|
Combination therapies of hdac inhibitors and tubulin inhibitors.
Provided herein are combination... |
|
2016
|
G/S
|
Development of pharmaceutical preparations and medicines; pharmaceutical product evaluation |
|
|
G/S
|
Development of pharmaceutical preparations and medicines;
pharmaceutical product evaluation. |
|
2010
|
Invention
|
Treatment of atrial fibrillation. Atrial fibrillation (AF) can be treated or prevented by adminis... |
|
|
Invention
|
Slow infusion of sulcardine and its salts. A composition comprised of an active agent that is 4-m... |
